| Issue Date | Title | Author(s) |
| 61 | 2015 | O-coumaric acid, caffeic acid, vanilic acid inhibits STAT pathway on malignant mesothelioma cell lines | Ulupınar, Z.; Cavus, O.; Gul, H.; Soyer, Ferda ; Zergeroğlu, A. Demiroğlu |
| 62 | 2023 | Plasmonic functional assay platform for measuring single cell growth through refractive index sensing | Avcı, Meryem Beyza; Topkaya, Seda Nur; Yalçın-Özuysal, Özden ; Khademhosseini, Ali; Çetin, Arif E. |
| 63 | 2013 | Ponatinib regulates major signaling pathways in imatinib-resistant chronic myeloid leukemia cells | Avcı, Çığır Biray; Kayabaşı, Çağla; Yılmaz Süslüer, Sunde; Balcı, Tuğçe; Saydam, Güray; Baran, Yusuf ; Gündüz, Cumhur |
| 64 | 2012 | Quercetin induced apoptosis in 232B4 chronic lymphocytic leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Apohan, Elif; Pişkin, Özden; Özcan, Mehmet Ali |
| 65 | 2016 | RNA sequencing (RNA-SEQ) reveals microRNA signatures involving in human T helper 17 cells differentiation | Nalbant, Ayten |
| 66 | 2017 | Role of Connexin 32 on gap junctions in breast cancer cells with varying metastatic potential. | Uğur, Deniz ; Özçivici, Engin ; Meşe, Gülistan |
| 67 | 2020 | Role of oxidative stress in the pathogenesis of Tay-Sachs disease mouse model | Ateş, Nurselin ; Başırlı, Hatice Hande; Çalışkan, Tufan Utku; Nalbant, Ayten ; Seyrantepe, Volkan |
| 68 | 2010 | The roles of STAT transcription Factors in imatinib resistance and sensitivity in BCR/ABL positive chronic myeloid leukemia cells | Baran, Yusuf ; Kosova, Buket; Tezcanlı, Burçin; Ekiz, Hüseyin Atakan ; Çakır, Zeynep; Selvi, Nur |
| 69 | 2015 | Sphingosine-1-phosphate receptor 2/GQ/Phospholıpase C Axis is a novel mechanism to overcome nilotinib resistance in T315I mutation expressing 32DCL3 murine cells | Adan Gökbulut, Aysun ; Öğretmen, Besim; Baran, Yusuf |
| 70 | 2014 | Suppression of STAT5A and STAT5B chronic myeloid leukemia cells via siRNA and antisense-oligonucleotide applications with the induction of apoptosis | Tezcanlı Kaymaz, Burçin; Selvi, Nur; Adan Gökbulut, Aysun ; Aktan, Çağdaş; Gündüz, Cumhur; Saydam, Güray; Baran, Yusuf ; Kosova, Buket |
| 71 | 2015 | Synergistic apoptotic effects of bortezomib and methylstat on different multiple myeloma cell lines | Kacı, Necmiye; Kiraz, Yağmur ; Baran, Yusuf |
| 72 | 2023 | T cell expressed microRNA-155 promotes antitumor immunity and immune checkpoint blockade responses in colon cancer through repression of Ship1 | Tang, William W.; Ekiz, H. Atakan ; Voth, Warren P.; Bauer, Kaylyn M.; Barba, Cindy; Ghazaryan, Arevik; Nelson, Morgan |
| 73 | 2009 | Targeting ceramide metabolism increased sensitivity of Philadelphia positif chronic megacaryoblastic leukemia cells to dasatinib | Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| 74 | 2015 | Therapeutic potential of fisetin and identification of its mechanisms in action in chronic myeloid leukemia and acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 75 | 2010 | Therapeutic potential of targeting sphingolipid signaling pathways in various types of cancers | Baran, Yusuf ; Başsoy, Esen Yonca; Çakır, Zeynep; Camgöz, Aylin; Gencer, Emel Başak; Kartal, Melis; Can, Geylani; Ekiz, Hüseyin Atakan ; Güçlüler, Gözde |
| 76 | 2012 | Zoledronate induces apoptosis via effecting on stat pathway in chronic myeloid leukemia cells | Saydam, Güray; Kiper, Hatice Demet; Tezcanlı, Burçin; Selvi, Nur; Avcı, Çığır Biray; Baran, Yusuf ; Şahin, Fahri |
